Examining the Differential Effects of Traditional Float-REST on Sleep and Recovery
1 other identifier
interventional
18
1 country
1
Brief Summary
The objective of this research study is to assess how the implementation of Float-REST affects sleep quality, sleep structure, nocturnal physiology, subjective wellness, recovery from stressors, and resultant effects on performance and well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2021
CompletedStudy Start
First participant enrolled
November 2, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2023
CompletedApril 25, 2025
April 1, 2025
12 months
September 24, 2021
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in Nocturnal Heart Rate as measured by OURA Ring
Heart rate (beats per minute) will be quantified throughout the night via the OURA ring.
Daily from baseline through study completion at 8 weeks
Change in Sleep Quantity as measured by Electroencephalography
Sleep stage duration (and the cumulative sleep duration) will be quantified each night via the Dreem headband, which uses Electroencephalography (EEG) for automatic sleep stage scoring.
Daily from baseline through study completion at 8 weeks
Change in Subjective Sleep Quality
A custom daily morning questionnaire will be used to record how a participant feels the quality of their sleep was the previous night (e.g. 1, very poor; 10 excellent). This questionnaire will be taken on the participants smartphone within 30 minutes of waking.
Daily from baseline through study completion at 8 weeks
Change in Nocturnal Heart Rate Variability as measured by OURA Ring
Heart rate variability will be quantified throughout the night via the OURA ring.
Daily from baseline through study completion at 8 weeks
Change in Anxiety surrounding Float-REST as measured by the State Trait Anxiety Index
Participants will complete the previously validated State Trait Anxiety Index (STAI) before and after each float session as a measure of subjective anxiety, where higher scores are suggestive of greater anxiety. State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions. Values range from 20 to 80, with higher scores representing more severe anxiety. Participants will complete the STAI questionnaire before and after each session. The sessions will take place during weeks 5-7.
Before and after each float session (Weeks 5-7)
Change in heart rate during Float-REST as measured via Electrocardiography
Participants will be monitored throughout float sessions using a heart rate monitor that will capture trends in cardiovascular physiology throughout the session.
During each float session (weeks 5-7)
Change in heart rate variability during Float-REST as measured via Electrocardiography
Participants will be monitored throughout float sessions using a heart rate monitor that will capture trends in cardiovascular physiology throughout the session.
During each float session (weeks 5-7)
Secondary Outcomes (17)
Change in Subjective Athens Insomnia Scale measured via questionnaire
Weekly throughout study completion at 8 weeks
Change in Subjective Epworth Sleepiness Scale measured via questionnaire
Weekly throughout study completion at 8 weeks
Change in Subjective Insomnia Severity Index measured via questionnaire
Weekly throughout study completion at 8 weeks
Change in Subjective Restorative Sleep Questionnaire
Weekly throughout study completion at 8 weeks
Change in Subjective Patient Reported Outcomes Measurement Information System measured via questionnaire
Weekly throughout study completion at 8 weeks
- +12 more secondary outcomes
Study Arms (1)
Traditional Float-REST Therapy
EXPERIMENTALParticipants will utilize sensory deprivation tanks.
Interventions
Traditional Float-REST therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. The room will contain an intercom that allows participants to communicate with study personnel in the event they need assistance. Participants will undergo 60 minute sessions three times a week for 3 weeks.
Eligibility Criteria
You may qualify if:
- Male or female 18-50 years of age
You may not qualify if:
- Has undergone travel across more than two collective time zones in the last two weeks
- Has a head diameter outside the range of 20.8-24 inches, or an approved head-mounted EEG device doesn't otherwise fit properly
- Has undergone a float-REST session of any kind in the last 3 months
- Has a fresh piercings that is less than 6 weeks old from scheduled session
- Has a fresh tattoo that is less than 4 weeks old from scheduled float
- Has an injury requiring an orthopedic cast (i.e. plaster or synthetic), irremovable splint or brace
- Is claustrophobic (fear of confined spaces)
- Has a skin or respiratory sensitivity or allergy to chlorine, sulfate, and/or magnesium
- Has a history of or is prone to motion sickness
- Has had an episode of loss of consciousness in the last 6-months
- Has had a concussion or traumatic brain injury in the last 6-months
- Has a contagious skin condition Has skin ulcers, open rashes, incisions, stiches or large open wounds that could cause pain when exposed to saltwater
- Has an irremovable medical port or catheter
- Has had a seizure in the last 10 years
- Has communicable diseases (e.g. HIV, Hepatitis A, B \& C, tuberculosis, or measles)
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rockefeller Neuroscience Institute at West Virginia University
Morgantown, West Virginia, 26505, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2021
First Posted
December 10, 2021
Study Start
November 2, 2021
Primary Completion
November 1, 2022
Study Completion
August 24, 2023
Last Updated
April 25, 2025
Record last verified: 2025-04